{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:53:02Z","timestamp":1791226382641,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T00:00:00Z","timestamp":1251849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s11033-009-9777-y","type":"journal-article","created":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T09:17:45Z","timestamp":1251796665000},"page":"2579-2586","source":"Crossref","is-referenced-by-count":48,"title":["Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro"],"prefix":"10.1007","volume":"37","author":[{"given":"Lin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,2]]},"reference":[{"key":"9777_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108. doi: 10.3322\/canjclin.55.2.74","journal-title":"CA Cancer J Clin"},{"key":"9777_CR2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3748\/wjg.v12.i3.354","volume":"12","author":"KD Crew","year":"2006","unstructured":"Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354\u2013362","journal-title":"World J Gastroenterol"},{"key":"9777_CR3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0039-6109(05)70205-X","volume":"80","author":"HJ Stein","year":"2000","unstructured":"Stein HJ, Sendler A, Fink U, Siewert JR (2000) Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am 80:659\u2013682. doi: 10.1016\/S0039-6109(05)70205-X","journal-title":"Surg Clin North Am"},{"key":"9777_CR4","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1038\/sj.onc.1203193","volume":"18","author":"N Ikematsu","year":"1999","unstructured":"Ikematsu N et al (1999) Tob2, a novel anti-proliferative Tob\/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene 18:7432\u20137441. doi: 10.1038\/sj.onc.1203193","journal-title":"Oncogene"},{"key":"9777_CR5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/geno.2000.6288","volume":"68","author":"P Buanne","year":"2000","unstructured":"Buanne P et al (2000) Cloning of PC3B, a novel member of the PC3\/BTG\/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium. Genomics 68:253\u2013263. doi: 10.1006\/geno.2000.6288","journal-title":"Genomics"},{"key":"9777_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-5793(01)02436-X","volume":"497","author":"S Matsuda","year":"2001","unstructured":"Matsuda S, Rouault J, Magaud J, Berthet C (2001) In search of a function for the Tis21\/PC3\/BTG1\/TOB family. FEBS Lett 497:67\u201372. doi: 10.1016\/S0014-5793(01)02436-X","journal-title":"FEBS Lett"},{"key":"9777_CR7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.leu.2400599","volume":"11","author":"F Guchenneux","year":"1997","unstructured":"Guchenneux F et al (1997) Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia 11:370\u2013375. doi: 10.1038\/sj.leu.2400599","journal-title":"Leukemia"},{"key":"9777_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jcp.1062","volume":"187","author":"T Felice","year":"2001","unstructured":"Felice T (2001) The gene PC3TIS21\/BTG2, prototype member of the PC3\/BTG\/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol 187:155\u2013165. doi: 10.1002\/jcp.1062","journal-title":"J Cell Physiol"},{"key":"9777_CR9","first-page":"343","volume":"1","author":"VP Sukhatme","year":"1987","unstructured":"Sukhatme VP, Kartha S, Toback FG, Taub R, Hoover RG, Tsaimorris CH (1987) A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res 1:343\u2013355","journal-title":"Oncogene Res"},{"key":"9777_CR10","doi-asserted-by":"crossref","first-page":"14511","DOI":"10.1016\/S0021-9258(18)98716-8","volume":"266","author":"BS Fletcher","year":"1991","unstructured":"Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA, Herschman HR (1991) Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem 266:14511\u201314518","journal-title":"J Biol Chem"},{"key":"9777_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0378-1119(01)00825-3","volume":"282","author":"C Duriez","year":"2002","unstructured":"Duriez C, Falette N, Audoynaud C, Moyret-Lalle C, Bensaad K, Courtois S, Wang Q, Soussi T, Puisieux A (2002) The human BTG2\/TIS21\/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene. Gene 282:207\u2013214. doi: 10.1016\/S0378-1119(01)00825-3","journal-title":"Gene"},{"key":"9777_CR12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF01209594","volume":"121","author":"IK Lim","year":"1995","unstructured":"Lim IK, Lee MS, Lee SH, Kim NK, Jou I, Seo JS, Park SC (1995) Differential expression of TIS21 and TIS1 genes in the various organs of Balb\/c mice, thymic carcinoma tissues and human cancer cell lines. J Cancer Res Clin Oncol 121:279\u20132848. doi: 10.1007\/BF01209594","journal-title":"J Cancer Res Clin Oncol"},{"key":"9777_CR13","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1158\/0008-5472.CAN-03-1687","volume":"64","author":"K Struckmann","year":"2004","unstructured":"Struckmann K, Schraml P, Simon R, Elmenhorst K, Mirlacher M, Kononen J, Moch H (2004) Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res 64:1632\u20131638. doi: 10.1158\/0008-5472.CAN-03-1687","journal-title":"Cancer Res"},{"key":"9777_CR14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/carcin\/22.8.1271","volume":"22","author":"MA Ficazzola","year":"2001","unstructured":"Ficazzola MA, Fraiman M, Gitlin J, Woo K, Melamed J, Rubin MA, Walden PD (2001) Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 22:1271\u20131279. doi: 10.1093\/carcin\/22.8.1271","journal-title":"Carcinogenesis"},{"key":"9777_CR15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1745-7262.2005.00031.x","volume":"7","author":"Y Wang","year":"2005","unstructured":"Wang Y, Shao C, Shi CH, Zhang L, Yue HH, Wang PF, Yang B, Zhang YT, Liu F, Qin WJ, Wang H, Shao GX (2005) Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism. Asian J Androl 7:375\u2013380. doi: 10.1111\/j.1745-7262.2005.00031.x","journal-title":"Asian J Androl"},{"key":"9777_CR16","first-page":"117","volume":"11","author":"Y Shaobo","year":"2004","unstructured":"Shaobo Y, Mengwei W, Yong S, Weidi Y, Weihua W (2004) Screening differentially expressed genes of gastric adenocarcinoma by cDNA microarray. China J Cancer Prev Treat 11:117\u2013120","journal-title":"China J Cancer Prev Treat"},{"key":"9777_CR17","first-page":"110","volume":"21","author":"Y Shao","year":"2004","unstructured":"Shao Y, Yang SB, Wang MW, Wu BY, You WD, Li H (2004) Gene expression profile of human adenocarcinoma by cDNA microarray and clustering. Chin J Med Genet 21:110\u2013115","journal-title":"Chin J Med Genet"},{"key":"9777_CR18","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1096\/fj.06-7548com","volume":"21","author":"S Farioli-Vecchioli","year":"2007","unstructured":"Farioli-Vecchioli S, Tanori M, Micheli L, Mancuso M, Leonardi L, Saran A, Ciotti MT, Ferretti E, Gulino A, Pazzaglia S, Tirone F (2007) Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3. FASEB J 21:2215\u20132225. doi: 10.1096\/fj.06-7548com","journal-title":"FASEB J"},{"key":"9777_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-006-0080-1","volume":"132","author":"IK Lim","year":"2006","unstructured":"Lim IK (2006) TIS21 (\/BTG2\/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule. J Cancer Res Clin Oncol 132:417\u2013426. doi: 10.1007\/s00432-006-0080-1","journal-title":"J Cancer Res Clin Oncol"},{"key":"9777_CR20","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1158\/0008-5472.CAN-06-0379","volume":"66","author":"H Kawakubo","year":"2006","unstructured":"Kawakubo H, Brachtel E, Hayashida T, Yeo G, Kish J, Muzikansky A, Walden PD, Maheswaran S (2006) Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein. Cancer Res 66:7075\u20137082. doi: 10.1158\/0008-5472.CAN-06-0379","journal-title":"Cancer Res"},{"key":"9777_CR21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1158\/0008-5472.CAN-06-0989","volume":"67","author":"LJ Donato","year":"2007","unstructured":"Donato LJ, Suh JH, Noy N (2007) Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Cancer Res 67:609\u2013615. doi: 10.1158\/0008-5472.CAN-06-0989","journal-title":"Cancer Res"},{"key":"9777_CR22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cellsig.2009.01.027","volume":"21","author":"C Evangelisti","year":"2009","unstructured":"Evangelisti C, Astolfi A, Gaboardi GC, Tazzari P, Pession A, Goto K, Martelli AM (2009) TIS21\/BTG2\/PC3 and cyclin D1 are key determinants of nuclear diacylglycerol kinase-zeta-dependent cell cycle arrest. Cell Signal 21:801\u2013809. doi: 10.1016\/j.cellsig.2009.01.027","journal-title":"Cell Signal"},{"key":"9777_CR23","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1128\/MCB.20.5.1797-1815.2000","volume":"20","author":"D Guardavaccaro","year":"2000","unstructured":"Guardavaccaro D, Corrente G, Covone F, Micheli L, D\u2019Agnano I, Starace G, Caruso M, Tirone F (2000) Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 20:1797\u20131815. doi: 10.1128\/MCB.20.5.1797-1815.2000","journal-title":"Mol Cell Biol"},{"key":"9777_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.yexcr.2004.05.014","volume":"299","author":"MS Ryu","year":"2004","unstructured":"Ryu MS, Lee MS, Hong JW, Hahn TR, Moon E, Lim IK (2004) TIS21\/BTG2\/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression. Exp Cell Res 299:159\u2013170. doi: 10.1016\/j.yexcr.2004.05.014","journal-title":"Exp Cell Res"},{"key":"9777_CR25","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1038\/sj.onc.1205888","volume":"21","author":"F el-Ghissassi","year":"2002","unstructured":"el-Ghissassi F, Valsesia-Wittmann S, Falette N, Duriez C, Walden PD, Puisieux A (2002) BTG2(TIS21\/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells. Oncogene 21:6772\u20136778. doi: 10.1038\/sj.onc.1205888","journal-title":"Oncogene"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-009-9777-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-009-9777-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-009-9777-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T07:14:45Z","timestamp":1633850085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-009-9777-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,2]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["9777"],"URL":"https:\/\/doi.org\/10.1007\/s11033-009-9777-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,2]]}}}